| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |